IL10 and cancer: IL-10 (Figure 7G) trended to decrease in Omicron-infected cancer patients and Omicron-infected non-cancer-afflicted subjects at the early stage, and its increase in non-cancer-afflicted subjects was higher than that in cancer patients at the late stage.